CARDIOZYME CK-CONTROL ABNORMAL— 510(k) K770971
Substantially EquivalentDade, Baxter Travenol Diagnostics, Inc.
FDA 510(k) clearance K770971 for CARDIOZYME CK-CONTROL ABNORMAL, Substantially Equivalent on 1977-08-04. Applicant: Dade, Baxter Travenol Diagnostics, Inc.. Device class: 1.
Clearance details
- Applicant
- Dade, Baxter Travenol Diagnostics, Inc.
- Product code
- Code JJT
- Device class
- Class 1
- Regulation
- 21 CFR 862.1660
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Mchenry, IL, US
Recent devices under product code JJT
view all- K090940 — SPOTCHECK BLOOD SPOT CONTROL, ASSAYED
- K062751 — MODIFICATION TO QUANTIMETRIX CARDIASURE CARDIAC MARKER
- K030768 — CLINIQA LIQUID QC CARDIAC MARKER CONTROL LEVELS 1, 2 & 3, TRI-LEVEL
- K030102 — ADVIA CENTAUR AND ACS:180 LIQUID CARDIAC MARKERS 1, 2, 3
- K021498 — LIQUICHEK CARDIAC MARKERS CONTROL LT LEVEL 1, 2, 3, AND TRILEVEL
More clearances from Dade, Baxter Travenol Diagnostics, Inc.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.